{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:53:13Z","timestamp":1775868793353,"version":"3.50.1"},"reference-count":54,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sardegna Ricerche (Italy)","award":["IBERNAT-NBL, P.O.R. Sardegna 2014-2020, CUP F21B17000730005"],"award-info":[{"award-number":["IBERNAT-NBL, P.O.R. Sardegna 2014-2020, CUP F21B17000730005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Histone deacetylase (HDAC) inhibitors are novel chemotherapy agents with potential utility in the treatment of neuroblastoma, the most frequent solid tumor of childhood. Previous studies have shown that the exposure of human neuroblastoma cells to some HDAC inhibitors enhanced the expression of the common neurotrophin receptor p75NTR. In the present study we investigated whether the upregulation of p75NTR could be exploited to render neuroblastoma cells susceptible to the cytotoxic action of an anti-p75NTR antibody conjugated to the toxin saporin-S6 (p75IgG-Sap). We found that two well-characterized HDAC inhibitors, valproic acid (VPA) and entinostat, were able to induce a strong expression of p75NTR in different human neuroblastoma cell lines but not in other cells, with entinostat, displaying a greater efficacy than VPA. Cell pretreatment with entinostat enhanced p75NTR internalization and intracellular saporin-S6 delivery following p75IgG-Sap exposure. The addition of p75IgG-Sap had no effect on vehicle-pretreated cells but potentiated the apoptotic cell death that was induced by entinostat. In three-dimensional neuroblastoma cell cultures, the subsequent treatment with p75IgG-Sap enhanced the inhibition of spheroid growth and the impairment of cell viability that was produced by entinostat. In athymic mice bearing neuroblastoma xenografts, chronic treatment with entinostat increased the expression of p75NTR in tumors but not in liver, kidney, heart, and cerebellum. The administration of p75IgG-Sap induced apoptosis only in tumors of mice that were pretreated with entinostat. These findings define a novel experimental strategy to selectively eliminate neuroblastoma cells based on the sequential treatment with entinostat and a toxin-conjugated anti-p75NTR antibody.<\/jats:p>","DOI":"10.3390\/ijms23073849","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:34:29Z","timestamp":1648762469000},"page":"3849","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7330-2179","authenticated-orcid":false,"given":"Simona","family":"Dedoni","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Olianas","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Section of Biochemistry, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-9915","authenticated-orcid":false,"given":"Barbara","family":"Manconi","sequence":"additional","affiliation":[{"name":"Department of Life and Environmental Sciences, Section of Biochemistry, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Collu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Tuveri","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Vincis","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Olianas","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Onali","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s12276-018-0077-2","article-title":"Targeting of epigenetic regulators in neuroblastoma","volume":"50","author":"Jubierre","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"578770","DOI":"10.3389\/fcell.2020.578770","article-title":"Histone deacetylases and histone deacetylase inhibitors in neuroblastoma","volume":"8","author":"Phimmachanh","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_7","first-page":"166","article-title":"Histone deacetylase inhibitors: Molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2000-9677","article-title":"Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma","volume":"212","author":"Eggert","year":"2000","journal-title":"Klin. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0079-6123(03)46015-9","article-title":"Neural crest development and neuroblastoma: The genetic and biological link","volume":"146","author":"Nakagawara","year":"2004","journal-title":"Prog. Brain Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1158\/1078-0432.CCR-08-1815","article-title":"Trk receptor expression in neuroblastomas","volume":"15","author":"Brodeur","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"OF1","DOI":"10.1158\/1078-0432.CCR-08-0651","article-title":"On Trk- the TrkB signal transduction pathway is an increasingly important target in cancer biology","volume":"15","author":"Thiele","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.25674","article-title":"The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signalling and is synergistic with topotecan","volume":"117","author":"Zage","year":"2011","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00280-013-2071-7","article-title":"p75NTR: An enhancer of fenretinide toxicity in neuroblastoma","volume":"71","author":"Ganeshan","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","article-title":"Larotrectinib for paediatric tumours harbouring NTRK gene fusions: A multicentre, open-label, phase 1 study","volume":"19","author":"Laetsch","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.119.258129","article-title":"Downregulation of TrkB expression and signaling by valproic acid and other histone deacetylase inhibitors","volume":"370","author":"Dedoni","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Dedoni, S., Marras, L., Olianas, M.C., Ingianni, A., and Onali, P. (2021). The neurotrophin receptor TrkC as a novel molecular target of the antineuroblastoma action of valproic acid. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157790"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10495-020-01626-0","article-title":"Valproic acid upregulates the expression of the p75NTR\/sortilin receptor complex to induce neuronal apoptosis","volume":"25","author":"Dedoni","year":"2020","journal-title":"Apoptosis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/0008-5472.CAN-11-0961","article-title":"EZH2 mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/cdd.2010.187","article-title":"CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression","volume":"18","author":"Liu","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1158\/0008-5472.CAN-10-2627","article-title":"A SP1\/MIZ1\/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF","volume":"71","author":"Iraci","year":"2010","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/toxins3060697","article-title":"Immunotoxins and other conjugates containing saporin-S6 for cancer therapy","volume":"3","author":"Polito","year":"2011","journal-title":"Toxins"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/toxins5101698","article-title":"Saporin-S6: A useful tool in cancer therapy","volume":"5","author":"Polito","year":"2013","journal-title":"Toxins"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2016.07.004","article-title":"Antibody therapy targeting CD47 and CD271 effectively suppresses melanoma metastasis in patient-derived xenografts","volume":"16","author":"Ngo","year":"2016","journal-title":"Cell Rep."},{"key":"ref_24","first-page":"57","article-title":"Saporin immunotoxins","volume":"234","author":"Flavell","year":"1998","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.103.055541","article-title":"Identification of novel isoform-selective inhibitors within class I histone deacetylases","volume":"307","author":"Hu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/13543784.2011.613822","article-title":"Entinostat for treatment of solid tumors and hematologic malignancies","volume":"20","author":"Knipstein","year":"2011","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1016\/S0021-9258(17)39561-3","article-title":"Characterization of the human melanoma nerve growth factor receptor","volume":"260","author":"Grob","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2147\/OTT.S33374","article-title":"Survivin\u2014Biology and potential as a therapeutic target in oncology","volume":"6","author":"Cheung","year":"2013","journal-title":"Onco Targets Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1087057104265040","article-title":"The use of 3-D cultures for high-throughput screening: The multicellular spheroid model","volume":"9","author":"Freyer","year":"2004","journal-title":"J. Biomol. Screen."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","article-title":"A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors","volume":"96","author":"Saito","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","first-page":"6108","article-title":"MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors","volume":"62","author":"Jaboin","year":"2002","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2016.00081","article-title":"Inhibition of HDAC3- and HDAC6-promoted survivin expression plays an important role in SAHA-induced autophagy and viability in breast cancer cells","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-07-0812","article-title":"Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21cip1-dependent decrease in survivin levels","volume":"67","author":"Nawrocky","year":"2007","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.102.042903","article-title":"Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin","volume":"304","author":"Bruwiere","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00018-006-6078-7","article-title":"Ribosome-inactivating proteins: Progress and problems","volume":"63","author":"Stirpe","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(05)70294-4","article-title":"Anti-apoptosis gene, survivin, and prognosis of neuroblastoma","volume":"351","author":"Adida","year":"1998","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/jpsu.2001.28839","article-title":"The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma","volume":"36","author":"Azuhata","year":"2001","journal-title":"J. Pediatr. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.onc.1203358","article-title":"High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma","volume":"19","author":"Islam","year":"2000","journal-title":"Oncogene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/jpsu.2002.30857","article-title":"The survivin: Fas ratio is predictive of recurrent disease in neuroblastoma","volume":"37","author":"Sandler","year":"2002","journal-title":"J. Pediatr. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejca.2011.10.012","article-title":"Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression","volume":"48","author":"Lamers","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ijc.24291","article-title":"Survivin minigene DNA vaccination is effective against neuroblastoma","volume":"125","author":"Fest","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e2410","DOI":"10.1038\/cddis.2016.257","article-title":"Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance","volume":"7","author":"Voges","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/cells4020135","article-title":"HDAC family members intertwined in the regulation of autophagy: A druggable vulnerability in aggressive tumor entities","volume":"4","author":"Koeneke","year":"2015","journal-title":"Cells"},{"key":"ref_45","first-page":"40","article-title":"Bioengineering 3D environments for cancer models","volume":"79","author":"Semino","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.biotechadv.2014.07.009","article-title":"Three-dimensional in vitro tumor models for cancer research and drug evaluation","volume":"32","author":"Xu","year":"2014","journal-title":"Biotecnol. Adv."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00383-008-2245-2","article-title":"Three-dimensional neuroblastoma cell culture: Proteomic analysis between monolayer and multicellular tumor spheroids","volume":"24","author":"Kumar","year":"2008","journal-title":"Pediatr. Surg. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"28951","DOI":"10.1038\/srep28951","article-title":"Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery","volume":"6","author":"Stock","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gong, X., Lin, C., Cheng, J., Su, J., Zhao, H., Liu, T., Wen, X., and Zhao, P. (2015). Generation of multicellular tumor spheroids with microwell-based agarose scaffolds for drug testing. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130348"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-4159.2012.07766.x","article-title":"Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons","volume":"122","author":"Dedoni","year":"2012","journal-title":"J. Neurochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/sj.onc.1200972","article-title":"Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells","volume":"14","author":"Bunone","year":"1997","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A","article-title":"p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA","volume":"35","author":"Eggert","year":"2000","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_53","first-page":"906","article-title":"Cotransfection of TrkA and p75 (NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells","volume":"116","author":"Chen","year":"2003","journal-title":"Chin. Med. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/ijc.24204","article-title":"The low affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma\/ganglioneuroma and reduces tumorigenity of neuroblastoma cells in vivo","volume":"124","author":"Schulte","year":"2009","journal-title":"Int. J. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3849\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:47:16Z","timestamp":1760136436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073849"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073849","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]}}}